Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate vs leuprorelin for preoperative treatment of symptomatic uterine fibroids
CTR20171179Phase 3Suspended
- Sponsor
- Jiangsu Jirui Pharmaceutical
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ulipristal in Fibromyoma (LM), sponsored by Jiangsu Jirui Pharmaceutical. Started Nov 2017; status: suspended.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on CTR20171179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171179.